211 related articles for article (PubMed ID: 21656657)
21. Hepatocellular carcinoma and liver transplantation.
Washburn K; Halff G
Curr Opin Organ Transplant; 2011 Jun; 16(3):297-300. PubMed ID: 21505342
[TBL] [Abstract][Full Text] [Related]
22. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
23. Liver transplantation for hepatocellular carcinoma using extended criteria donor grafts.
Sotiropoulos GC; Tagkalos E; Fouzas I; Vernadakis S; Mathé Z; Treckmann J; Paul A
Transplant Proc; 2012 Nov; 44(9):2730-3. PubMed ID: 23146507
[TBL] [Abstract][Full Text] [Related]
24. [Selection criteria decisive in hepatocellular carcinoma].
Söderdahl G; Eilard MS; Rizell M
Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1750-3. PubMed ID: 23097883
[No Abstract] [Full Text] [Related]
25. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
Stock PG; Fung J
Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
[No Abstract] [Full Text] [Related]
26. 2010 International Consensus Conference on Liver Transplantation for Hepatocellular Carcinoma: texts of experts.
Lesurtel M; Clavien PA
Liver Transpl; 2011 Oct; 17 Suppl 2():S1-5. PubMed ID: 21656651
[No Abstract] [Full Text] [Related]
27. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
28. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
Olthoff KM; Forner A; Hübscher S; Fung J
Liver Transpl; 2011 Oct; 17 Suppl 2():S26-33. PubMed ID: 21656653
[No Abstract] [Full Text] [Related]
29. Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient?
Schwartz ME
Hepatology; 1996 Dec; 24(6):1539-41. PubMed ID: 8938193
[No Abstract] [Full Text] [Related]
30. Should we expand the criteria for liver transplantation for hepatocellular carcinoma--yes, of course!
Broelsch CE; Frilling A; Malago M
J Hepatol; 2005 Oct; 43(4):569-73. PubMed ID: 16120470
[No Abstract] [Full Text] [Related]
31. Surgical treatment for hepatocellular carcinoma.
Takayama T
Jpn J Clin Oncol; 2011 Apr; 41(4):447-54. PubMed ID: 21411469
[TBL] [Abstract][Full Text] [Related]
32. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
Teng da H; Zhu ZJ; Zheng H; Deng YL; Sun LY; Pan C; Liu YH; Song HL; Shen ZY
Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
[TBL] [Abstract][Full Text] [Related]
33. Is the treatment of hepatocellular carcinoma on the waiting list necessary?
Majno P; Lencioni R; Mornex F; Girard N; Poon RT; Cherqui D
Liver Transpl; 2011 Oct; 17 Suppl 2():S98-108. PubMed ID: 21954097
[No Abstract] [Full Text] [Related]
34. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
35. Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma.
Choi HJ; Kim DG; Na GH; Hong TH; You YK
Transplant Proc; 2012 Mar; 44(2):399-402. PubMed ID: 22410027
[TBL] [Abstract][Full Text] [Related]
36. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
[TBL] [Abstract][Full Text] [Related]
37. Role of adult living liver donation in patients with hepatocellular cancer.
Roberts JP
Liver Transpl; 2003 Oct; 9(10 Suppl 2):S60-3. PubMed ID: 14528431
[No Abstract] [Full Text] [Related]
38. Impact of a living donor liver transplant program for hepatocellular carcinoma to the running local deceased donor liver transplant program.
Sotiropoulos GC; Malagó M; Molmenti EP; Radtke A; Fouzas I; Beckebaum S; Saner FH; Paul A; Lang H; Broelsch CE
Dig Dis Sci; 2010 Mar; 55(3):872-3. PubMed ID: 19294504
[No Abstract] [Full Text] [Related]
39. [Evaluation of living donor liver transplantation for patients with hepatocellular carcinoma].
Jiang XZ; Yan LN; Li B; Wen TF; Zeng Y; Zhao JC; Wang WT; Yang JY; Xu MQ; Chen ZY; Ma YK; Li FG; Gong G
Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):3-6. PubMed ID: 18226334
[TBL] [Abstract][Full Text] [Related]
40. Ethical dilemmas in living donor liver transplantation.
Soin AS
Issues Med Ethics; 2003; 11(4):104-5. PubMed ID: 16335516
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
